Guangzhou Jet Biofiltration Co (SHSE:688026) NonCurrent Deferred Liabilities: ¥0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688026 Guangzhou Jet Biofiltration Co Ltd SHSE:688026
74 GF Score
Price ¥18.19
GF Value ¥18.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Guangzhou Jet Biofiltration Co NonCurrent Deferred Liabilities?

Guangzhou Jet Biofiltration Co SHSE:688026 -1.94% 74 NonCurrent Deferred Liabilities is ¥0.0 Mil as of Mar. 2026. GuruFocus rates SHSE:688026 with a GF Score™ of 74/100 and a GF Value™ of ¥18.49 (Fairly Valued). The stock has 5 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Guangzhou Jet Biofiltration Co's non-current deferred liabilities for the quarter that ended in Mar. 2026 was ¥0.0 Mil.

Guangzhou Jet Biofiltration Co NonCurrent Deferred Liabilities Related Terms

Guangzhou Jet Biofiltration Co NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Guangzhou Jet Biofiltration Co's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Jet Biofiltration Co NonCurrent Deferred Liabilities Chart

Guangzhou Jet Biofiltration Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Guangzhou Jet Biofiltration Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:688026
74GF Score
Guangzhou Jet Biofiltration Co Ltd SHSE:688026
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of ¥0.0 Mil mean?
Guangzhou Jet Biofiltration Co (SHSE:688026) has a NonCurrent Deferred Liabilities of ¥0.0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Guangzhou Jet Biofiltration Co and its competitors.
Is Guangzhou Jet Biofiltration Co's NonCurrent Deferred Liabilities too high?
Guangzhou Jet Biofiltration Co's current NonCurrent Deferred Liabilities is ¥0.0 Mil. Overall, Guangzhou Jet Biofiltration Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Jet Biofiltration Co's NonCurrent Deferred Liabilities compare to ISRG and BDX?
Guangzhou Jet Biofiltration Co's NonCurrent Deferred Liabilities of ¥0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Guangzhou Jet Biofiltration Co and its competitors. Guangzhou Jet Biofiltration Co's current NonCurrent Deferred Liabilities is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Jet Biofiltration Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co (SHSE:688026) is currently considered Fairly Valued. The stock's GF Value™ is ¥18.49, compared to a current price of ¥18.19 — trading 1.6% below its estimated fair value. The current NonCurrent Deferred Liabilities is ¥0.0 Mil. Guangzhou Jet Biofiltration Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Guangzhou Jet Biofiltration Co (SHSE:688026), the current NonCurrent Deferred Liabilities is ¥0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Jet Biofiltration Co (SHSE:688026) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co stock appears to be undervalued. The current stock price of ¥18.19 is trading 1.6% below its estimated GF Value™ of ¥18.49. GuruFocus considers Guangzhou Jet Biofiltration Co to be Fairly Valued.

Key valuation signals for SHSE:688026:

  • NonCurrent Deferred Liabilities: ¥0.0 Mil
  • GF Value™: ¥18.49 vs. price of ¥18.19 (1.6% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688026 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou Jet Biofiltration Co Business Description

Address No. 1 Dou Tang Road, YongHe Development Zone, Guangzhou, CHN, 511356
Guangzhou Jet Biofiltration Co Ltd is engaged in the research and development, manufacturing and sales of laboratory consumable products. Its main products include laboratory consumables (pipettes, tissue culture products, centrifuge tubes, filtration products) analyzer, lab equipment and others.
74GF Score

Get the complete analysis for SHSE:688026

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.19
Price
¥18.49
GF Value